The association of lung function and pulmonary vasculature volume with cardiorespiratory fitness in the community
- PMID: 34996832
- PMCID: PMC9259762
- DOI: 10.1183/13993003.01821-2021
The association of lung function and pulmonary vasculature volume with cardiorespiratory fitness in the community
Abstract
Background: Cardiorespiratory fitness is not limited by pulmonary mechanical reasons in the majority of adults. However, the degree to which lung function contributes to exercise response patterns among ostensibly healthy individuals remains unclear.
Methods: We examined 2314 Framingham Heart Study participants who underwent cardiopulmonary exercise testing (CPET) and pulmonary function testing. We investigated the association of forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC and diffusing capacity of the lung for carbon monoxide (D LCO) with the primary outcome of peak oxygen uptake (V'O2 ) along with other CPET parameters using multivariable linear regression. Finally, we investigated the association of total and peripheral pulmonary blood vessel volume with peak V'O2 .
Results: We found lower FEV1, FVC and D LCO were associated with lower peak V'O2 . For example, a 1 L lower FEV1 and FVC was associated with a 7.1% (95% CI 5.1-9.1%) and 6.0% (95% CI 4.3-7.7%) lower peak V'O2 , respectively. By contrast, FEV1/FVC was not associated with peak V'O2 . Lower lung function was associated with lower oxygen uptake efficiency slope, oxygen pulse slope, V'O2 at anaerobic threshold (AT), minute ventilation (V'E) at AT and breathing reserve. In addition, lower total and peripheral pulmonary blood vessel volume were associated with lower peak V'O2 .
Conclusions: In a large, community-based cohort of adults, we found lower FEV1, FVC and D LCO were associated with lower exercise capacity, as well as oxygen uptake efficiency slope and ventilatory efficiency. In addition, lower total and peripheral pulmonary blood vessel volume were associated with lower peak V'O2 . These findings underscore the importance of lung function and blood vessel volume as contributors to overall exercise capacity.
Copyright ©The authors 2022. For reproduction rights and permissions contact permissions@ersnet.org.
Conflict of interest statement
Conflict of interest: J. McNeill has nothing to disclose. Conflict of interest: A. Chernofsky has nothing to disclose. Conflict of interest: M. Nayor reports grants from the NIH, during the conduct of the study. Conflict of interest: F.N. Rahaghi has nothing to disclose. Conflict of interest: R. San Jose Estepar has contracts with Lung Biotechnology, Insmed and Boehringer Ingelheim, receives consulting fees from Leuko Labs, and has stock options in Quantitative Imaging Solutions. Conflict of interest: G. Washko reports grants from the NIH, DoD, Boehringer Ingelheim, Janssen Pharmaceuticals, BTG Therapeutics, Pulmonx, Lung Biotechnology and Insmed; participation in advisory boards and consultancies for Boehringer Ingelheim, CSL Behring, Novartis, Phillips and Vertex Pharmaceuticals; is a co-founder and equity shareholder in Quantitative Imaging Solutions, a company that provides consulting services for image and data analytics; finally, the author's spouse works for Biogen. Conflict of interest: A. Synn reports grants from the American Lung Association and NHLBI, outside the submitted work. Conflict of interest: R.S. Vasan has nothing to disclose. Conflict of interest: G. O'Connor has nothing to disclose. Conflict of interest: M.G. Larson has nothing to disclose. Conflict of interest: J.E. Ho reports grants from the NIH/NHLBI, during the conduct of the study; research support from Gilead Sciences and Bayer AG, and research supplies from EcoNugenics, outside the submitted work. Conflict of interest: G.D. Lewis reports grants from Amgen, Cytokinetics, AstraZeneca, Applied Therapeutics and Sonivie, personal fees and other for advisory board work from American Regent, outside the submitted work.
Figures



Similar articles
-
Phenotyping Exertional Breathlessness Using Cardiopulmonary Cycle Exercise Testing in People With Chronic Airflow Limitation.Chest. 2025 Aug;168(2):379-389. doi: 10.1016/j.chest.2025.02.033. Epub 2025 Mar 11. Chest. 2025. PMID: 40081656
-
Spiroergometric parameters at maximal exercise testing assessed functional respiratory impairment in asbestos-induced fibrosis.Clin Respir J. 2014 Apr;8(2):175-84. doi: 10.1111/crj.12055. Epub 2013 Nov 28. Clin Respir J. 2014. PMID: 24028216
-
Relationship between daily physical activity and aerobic fitness in adults with cystic fibrosis.BMC Pulm Med. 2015 May 9;15:59. doi: 10.1186/s12890-015-0036-9. BMC Pulm Med. 2015. PMID: 25952747 Free PMC article.
-
Ventilatory response to exercise in cardiopulmonary disease: the role of chemosensitivity and dead space.Eur Respir J. 2018 Feb 7;51(2):1700860. doi: 10.1183/13993003.00860-2017. Print 2018 Feb. Eur Respir J. 2018. PMID: 29437936 Review.
-
Functional evaluation of the lung resection candidate.Eur Respir J. 1998 Jan;11(1):198-212. doi: 10.1183/09031936.98.11010198. Eur Respir J. 1998. PMID: 9543294 Review.
Cited by
-
The association of cardiorespiratory fitness with spirometric small airway obstruction.ERJ Open Res. 2023 Aug 29;9(4):00275-2023. doi: 10.1183/23120541.00275-2023. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37650082 Free PMC article.
-
Is the Lung Built for Exercise? Advances and Unresolved Questions.Med Sci Sports Exerc. 2023 Dec 1;55(12):2143-2159. doi: 10.1249/MSS.0000000000003255. Epub 2023 Jul 14. Med Sci Sports Exerc. 2023. PMID: 37443459 Free PMC article. Review.
-
Relationship of Pulmonary Vascular Structure and Function With Exercise Capacity in Health and COPD.Chest. 2025 Feb;167(2):402-413. doi: 10.1016/j.chest.2024.09.027. Epub 2024 Oct 3. Chest. 2025. PMID: 39368737 Free PMC article.
-
Inspiratory-Expiratory Muscle Training Improved Respiratory Muscle Strength in Dialysis Patients: A Pilot Randomised Trial.Adv Respir Med. 2023 Feb 10;91(1):93-102. doi: 10.3390/arm91010009. Adv Respir Med. 2023. PMID: 36825943 Free PMC article. Clinical Trial.
References
-
- Mora S, Redberg RF, Cui Y, et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA. 2003;290(12):1600–1607. - PubMed
-
- Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024–2035. - PubMed
-
- Clausen JSR, Marott JL, Holtermann A, Gyntelberg F, Jensen MT. Midlife Cardiorespiratory Fitness and the Long-Term Risk of Mortality: 46 Years of Follow-Up. J Am Coll Cardiol. 2018;72(9):987–995. - PubMed
-
- Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr., Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83(3):778–786. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL140224/HL/NHLBI NIH HHS/United States
- R01 HL131029/HL/NHLBI NIH HHS/United States
- HHSN268201500001C/HL/NHLBI NIH HHS/United States
- K23 HL136905/HL/NHLBI NIH HHS/United States
- R01 HL159514/HL/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- HHSN268201500001I/HL/NHLBI NIH HHS/United States
- R01 HL151841/HL/NHLBI NIH HHS/United States
- 75N92019D00031/HL/NHLBI NIH HHS/United States
- K23 HL138260/HL/NHLBI NIH HHS/United States
- F32 HL143819/HL/NHLBI NIH HHS/United States
- K24 HL153669/HL/NHLBI NIH HHS/United States
- R01 HL134893/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources